loadpatents
name:-0.050623893737793
name:-0.012915134429932
name:-0.011565923690796
Junttila; Teemu T. Patent Filings

Junttila; Teemu T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Junttila; Teemu T..The latest application filed is for "treatment of cancer with her2xcd3 bispecific antibodies in combination with anti-her2 mab".

Company Profile
11.5.14
  • Junttila; Teemu T. - San Mateo CA
  • JUNTTILA; Teemu T. - South San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-FCRH5 antibodies
Grant 11,352,431 - Ebens , et al. June 7, 2
2022-06-07
Treatment Of Cancer With Her2xcd3 Bispecific Antibodies In Combination With Anti-her2 Mab
App 20220098325 - JUNTTILA; Teemu T. ;   et al.
2022-03-31
HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE
App 20220048993 - HOTZEL; Isidro ;   et al.
2022-02-17
Humanized and affinity matured antibodies to FcRH5 and methods of use
Grant 11,192,950 - Hotzel , et al. December 7, 2
2021-12-07
Anti-cd3 Antibodies And Methods Of Use
App 20200299408 - CHEN; Xiaocheng ;   et al.
2020-09-24
Anti-cd3 Antibodies And Methods Of Use
App 20200299409 - CHEN; Xiaocheng ;   et al.
2020-09-24
Anti-fcrh5 Antibodies
App 20200190185 - EBENS; Allen J. ;   et al.
2020-06-18
Anti-CD3 antibodies and methods of use
Grant 10,640,572 - Chen , et al.
2020-05-05
HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE
App 20190315860 - HOTZEL; Isidro ;   et al.
2019-10-17
Anti-FcRH5 antibodies
Grant 10,435,471 - Ebens , et al. O
2019-10-08
Bispecific Antigen-binding Molecules And Methods Of Use
App 20190270814 - ELLERMAN; Diego ;   et al.
2019-09-05
Humanized and affinity matured antibodies to FcRH5 and methods of use
Grant 10,323,094 - Hotzel , et al.
2019-06-18
Anti-cd3 Antibodies And Methods Of Use
App 20190112389 - CHEN; Xiaocheng ;   et al.
2019-04-18
Anti-cd3 Antibodies And Methods Of Use
App 20190016823 - CHEN; Xiaocheng ;   et al.
2019-01-17
Anti-cd3 Antibodies And Methods Of Use
App 20170204194 - CHEN; Xiaocheng ;   et al.
2017-07-20
Methods Of Treating Her2-positive Cancers Using Pd-1 Axis Binding Antagonists And Anti-her2 Antibodies
App 20170008971 - DENNIS; Mark S. ;   et al.
2017-01-12
HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE
App 20160368985 - HOTZEL; Isidro ;   et al.
2016-12-22
Anti-cd3 Antibodies And Methods Of Use
App 20150166661 - CHEN; Xiaocheng ;   et al.
2015-06-18
Anti-fcrh5 Antibodies
App 20150098900 - Ebens; Allen J. ;   et al.
2015-04-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed